Literature DB >> 937888

Rocky Mountain spotted fever: epidemiology of an increasing problem.

M A Hattwick, R J O'Brien, B F Hanson.   

Abstract

Reported cases of Rocky Mountain spotted fever in the United States have been increasing since 1960 and reached an all-time high of 754 cases in 1974. Detailed clinical and epidemiologic information was obtained on 1522 (55%) of the 2757 cases reported in the 5-year period 1970 through 1974. Fifty-one percent of cases were confirmed by one or more laboratory test. The increase has occurred predominantly in the southeastern part of the United States. A comparison of laboratory-confirmed and unconfirmed cases suggests that a variety of febrile exanthems may be confused with Rocky Mountain spotted fever. Neither a history of tick bite nor rash was universally present, and both were significantly less frequent in fatal cases. The overall death-to-case ratio during this period was 6.8%. Death-to-case ratios were significantly higher for nonwhites (13.9) than whites (5.8), for male patients (8.2) than female patients (4.5), and for person older than 30 (13.9) than persons younger than 30 (5.4).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 937888     DOI: 10.7326/0003-4819-84-6-732

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

Review 1.  Host, pathogen and treatment-related prognostic factors in rickettsioses.

Authors:  E Botelho-Nevers; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-26       Impact factor: 3.267

2.  The Rickettsia conorii autotransporter protein Sca1 promotes adherence to nonphagocytic mammalian cells.

Authors:  Sean P Riley; Kenneth C Goh; Timothy M Hermanas; Marissa M Cardwell; Yvonne G Y Chan; Juan J Martinez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

3.  Phylogeography of Rickettsia rickettsii genotypes associated with fatal Rocky Mountain spotted fever.

Authors:  Christopher D Paddock; Amy M Denison; R Ryan Lash; Lindy Liu; Brigid C Bollweg; F Scott Dahlgren; Cristina T Kanamura; Rodrigo N Angerami; Fabiana C Pereira dos Santos; Roosecelis Brasil Martines; Sandor E Karpathy
Journal:  Am J Trop Med Hyg       Date:  2014-06-23       Impact factor: 2.345

4.  Prophylactic treatment of Rocky Mountain spotted fever.

Authors:  R H Kenyon; R G Williams; C N Oster; C E Pedersen
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

5.  Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Davidson; D P Aucoin; M G Levy; N S Szabados; B C Hegarty; A L Kuehne; R L James
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 6.  Rocky Mountain spotted fever: a disease in need of microbiological concern.

Authors:  D H Walker
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

7.  Interleukin-1 alpha production during Rickettsia rickettsii infection of cultured endothelial cells: potential role in autocrine cell stimulation.

Authors:  L A Sporn; V J Marder
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

8.  Successful treatment of Rocky Mountain 'spotless' fever.

Authors:  P G Ramsey; O W Press
Journal:  West J Med       Date:  1984-01

9.  Studies of a "new" rickettsiosis "Astrakhan" spotted fever.

Authors:  I V Tarasevich; V A Makarova; N F Fetisova; A V Stepanov; E D Miskarova; D Raoult
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

10.  Fatal spotted fever rickettsiosis, Minas Gerais, Brazil.

Authors:  Márcio Antonio Moreira Galvâo; J Stephen Dumler; Cláudio Lísias Mafra; Simone Berger Calic; Chequer Buffe Chamone; Gracco Cesarino Filho; Juan Pablo Olano; David H Walker
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.